UB-Atrys Chair in Personalized Radiotherapy
The aim of the chair is to promote excellent research, specialized teaching and dissemination of knowledge in the field of precision radiation oncology.
Research in the framework of the new chair will focus on three main lines: personalization of radiotherapy treatments through radiosensitivity and radiotoxicity studies, predictive diagnosis prior to high-precision radiotherapy treatment, and the effect of radiotherapy on the immune response against cancer.
Director
Presentation
One of the notable activities that will be carried out to meet the aforementioned objectives is the call for the National Research Awards in Personalized Radiotherapy. Every year, these awards will be given to the three best research articles published in recognized scientific journals and in which the first or the last author belong to a research group established in Spain.
In addition, within the framework of this training activity, an annual conference on advances in translational research in radiotherapy will be held, with the participation of a speaker of international relevance. The conference will serve as a forum for the presentation and delivery of the awards.
Team
Director of the Department of Radiation Oncology at the Catalan Institute of Oncology (ICO). Full professor of Radiation Oncology at the UB, head of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL), president of the Technical Committee of the Spanish Association against Cancer in Catalunya, and an academic of the Royal Academy of Medicine of Catalonia.
Director of Radiation Oncology at the Institute of Advanced Oncology (IOA).
Vice-president of Oncology at Atrys Health, director of the IMOR Foundation and associate professor of the UB.
Clinical head of Radiation Oncology at the Catalan Institute of Oncology (ICO), part-time lecturer in Radiation Oncology at the UB and a member of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL).
Responsible for urology in the Radiation Oncology Service of the Catalan Institute of Oncology (ICO). He is a part-time lecturer in Radiation Oncology at the UB and member of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL).
Jointly responsible for tumours in the ORL sphere at the Radiation Oncology Service of the Catalan Institute of Oncology (ICO) and clinical head of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL). She is a part-time lecturer in Radiation Oncology at the UB.
She was a postdoctoral research scientist at Columbia University for almost four years. Responsible for biology in the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL), a group that she joined in 2019.
Jointly responsible for lung tumours in the Radiation Oncology Service of the Catalan Institute of Oncology (ICO) and a member of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL).
Attached to the Radiation Oncology Service of the Catalan Institute of Oncology (ICO) and a member of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL).
Coordinates the Brachytherapy Unit of the Radiation Oncology Service of the Catalan Institute of Oncology (ICO). She is a part-time lecturer at the UB and a member of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL).
Responsible for breast tumours and coordinator of the External Radiotherapy Unit of the Radiation Oncology Service of the Catalan Institute of Oncology (ICO), and a member of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL).
She is a fellow in radiobiology and bioinformatics at the University of California, San Francisco. She completed her internship in radiation oncology at the Catalan Institute of Oncology (ICO). She is a member of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL).
Holds a PhD in Genetics. He was director of Programmes of the Directorate General for Advanced Therapies and Transplantations and advisor to the Office of the General Secretariat of the Ministry of Health. He is a collaborating professor at the International School for Postgraduate Studies at the University of Granada, member of the European Society of Medical Oncology and the director of research, development and innovation at Atrys Health.
She is project manager for radiation oncology at the Catalan Institute of Oncology (ICO) and a member of the Radiobiology and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL).
